Safety and Tolerability of Tirbanibulin 1% Treatment of Actinic Keratosis on Face and Scalp in Routine Clinical Practice Across the U.S. (PROAK Study). J of Skin [Internet]. 2023 Nov. 13 [cited 2026 Apr. 17];7(6):s263. Available from: https://skin.dermsquared.com/skin/article/view/2338